PMA device
Her Option Cryoablation Therapy System
CooperSurgical, Inc. · Device, Thermal Ablation, Endometrial (MNB, Class III) · First FDA decision Aug 8, 2003, newest Nov 3, 2011Uterine fibroids and heavy menstrual bleeding
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
1
Naming "Her Option Cryoablation"
MAUDE reports
0
Brand "Her Option Cryoablation", since 2015
PubMed studies
0
Mentioning "Her Option Cryoablation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Her Option Cryoablation Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- HER OPTION CRYOABLATION THERAPY SYSTEMPMA supplement
P000032-S037 · Decided Nov 3, 2011 · 31 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, thermal ablation, endometrial (MNB) · Obstetrics & Gynecology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Her Option Cryoablation", any status and sponsor, newest update first.
CooperSurgical Inc.Not on our public-company list
NCT00094536 · 82 participants · Start Apr 2004 · Primary completion Oct 2007
Device: Extended treatment regimen using Her Option Cryotherapy · For: Menorrhagia
Sites: Phoenix, Arizona; Wellington, Florida; Burlington, Massachusetts · 7 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Her Option Cryoablation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MNB
2,839 reports: 909 malfunction, 1,913 injury, 13 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0675-06 · Started Jan 13, 2006 · Posted by FDA Mar 23, 2006
Reason given: Overheating of the Cryoablation Therapy Disposable Probe (CU-1), could cause a burn injury to a patient or user in certain circumstances.
Cause as FDA categorized it: Other · Device type: Device, Thermal Ablation, Endometrial (MNB)
Published research
The most relevant PubMed records for "Her Option Cryoablation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MNB.
- NovaSure Impedance Controlled Endometrial Ablation SystemHologic, Inc. · PMA 2022
- Genesys HTA SystemAxora Medical, Inc. · PMA 2022
- Minerva Endometrial Ablation SystemAxora Medical, Inc. · PMA 2025
- Mara Water Vapor Ablation SystemCooperSurgical, Inc. · PMA 2023
- Hydro Thermablator Endometrial Ablation SystemAxora Medical, Inc. · PMA 2020
- Cerene® Cryotherapy DeviceChannel Medsystems, Inc. · PMA 2026
- Minitouch 3.8 Era System (Minitouch System)Microcube, LLC · PMA 2026
- AEGEA Vapor SystemCooperSurgical, Inc. · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.